Novo Nordisk A/S (NONOF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Novo Nordisk A/S

    OTC: NONOF · Real-Time Price · USD
    54.50
    -0.32 (-0.58%)
    At close: Sep 08, 2025, 3:46 PM
    54.50
    0.00%
    After-hours: Sep 08, 2025, 03:46 PM EDT

    Novo Nordisk A/S Income Statement

    Financials in DKK. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 290.4B 232.26B 176.95B 140.8B
    Cost of Revenue
    		 44.52B 35.77B 28.45B 23.66B
    Gross Profit
    		 245.88B 196.5B 148.51B 117.14B
    Operating Income
    		 128.34B 102.57B 74.81B 58.64B
    Interest Income
    		 1.84B 1.07B 239M 231M
    Pretax Income
    		 127.19B 104.67B 69.06B 59.08B
    Net Income
    		 100.99B 83.68B 55.52B 47.76B
    Selling & General & Admin
    		 67.38B 61.6B 50.68B 41.06B
    Research & Development
    		 48.06B 32.44B 24.05B 17.77B
    Other Expenses
    		 2.1B -119M -1.03B -332M
    Operating Expenses
    		 117.54B 93.92B 73.7B 58.5B
    Interest Expense
    		 1.64B 739M 378M 289M
    Selling & Marketing Expenses
    		 62.1B 56.74B 46.22B 37.01B
    Cost & Expenses
    		 162.06B 129.69B 102.14B 82.16B
    Income Tax Expense
    		 26.2B 20.99B 13.54B 11.32B
    Shares Outstanding (Basic)
    		 4.45B 4.49B 4.53B 4.59B
    Shares Outstanding (Diluted)
    		 4.46B 4.49B 4.54B 4.61B
    EPS (Basic)
    		 22.68 9.34 12.26 10.40
    EPS (Diluted)
    		 22.64 9.31 12.22 10.37
    EBITDA
    		 137.38B 109.81B 76.8B 64.83B
    EBIT
    		 128.83B 105.22B 69.81B 59.52B
    Depreciation & Amortization
    		 8.54B 5.83B 5.31B 5.31B

    Add to Watchlist